Literature DB >> 35451654

Is periodontal inflamed surface area associated with serum and salivary levels of IL-1β, visfatin, and omentin-1 in overweight/obese patients?

Esra Sinem Kemer Doğan1, Nizami Duran2.   

Abstract

OBJECTIVES: The aim of this study was to evaluate the levels of salivary and serum interleukin (IL)-1β, visfatin, and omentin-1 in the relationship between periodontal disease and overweight/obesity as well as to reveal the possible role of periodontal inflamed surface area (PISA) in this association.
MATERIALS AND METHODS: Ninety-six individuals (69 females, 27 males) were divided into 4 groups as systemically healthy (H) and non-periodontitis (HnP, n = 23), systemically healthy and periodontitis (HP, n = 24), overweight/obese (O) and non-periodontitis (OnP, n = 25), and overweight/obese and periodontitis (OP, n = 24). Periodontal parameters were measured, and PISA was calculated. IL-1β, visfatin, and omentin-1 levels in saliva and serum samples were analysed.
RESULTS: Periodontal parameters deteriorated, salivary and serum IL-1β and visfatin levels were increased, and omentin-1 levels were decreased in OnP and OP groups, compared to HnP and HP groups. Salivary and serum IL-1β and visfatin levels were increased and omentin-1 levels were decreased in periodontitis groups, compared to HnP and OnP groups. PISA was negatively correlated with salivary omentin-1 and positively correlated with salivary and serum visfatin in H and O groups, whereas a positive relationship was found between PISA and salivary and serum IL-1β in H group.
CONCLUSIONS: PISA may be negatively associated with salivary omentin-1, while positively correlated with salivary and serum visfatin in overweight/obese patients. CLINICAL RELEVANCE: Co-evaluation of PISA and adipokines seems to be an innovative approach to evaluate the association between periodontitis and overweight/obesity.
© 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  Adipokines; Obesity; Overweight; Periodontal diseases

Mesh:

Substances:

Year:  2022        PMID: 35451654     DOI: 10.1007/s00784-022-04502-0

Source DB:  PubMed          Journal:  Clin Oral Investig        ISSN: 1432-6981            Impact factor:   3.606


  23 in total

1.  Obesity and periodontal disease in young, middle-aged, and older adults.

Authors:  Mohammad S Al-Zahrani; Nabil F Bissada; Elaine A Borawskit
Journal:  J Periodontol       Date:  2003-05       Impact factor: 6.993

2.  Visfatin: the link between inflammation and childhood obesity.

Authors:  George V Z Dedoussis; Alexandra Kapiri; Anastasia Samara; Dimitris Dimitriadis; Daniel Lambert; Michele Pfister; Gerard Siest; Sophie Visvikis-Siest
Journal:  Diabetes Care       Date:  2009-06       Impact factor: 19.112

3.  Periodontal inflamed surface area: quantifying inflammatory burden.

Authors:  Willem Nesse; Frank Abbas; Ids van der Ploeg; Frederik Karst Lucien Spijkervet; Pieter Ubele Dijkstra; Arjan Vissink
Journal:  J Clin Periodontol       Date:  2008-06-28       Impact factor: 8.728

4.  Plasma visfatin concentrations and fat depot-specific mRNA expression in humans.

Authors:  Janin Berndt; Nora Klöting; Susan Kralisch; Peter Kovacs; Mathias Fasshauer; Michael R Schön; Michael Stumvoll; Matthias Blüher
Journal:  Diabetes       Date:  2005-10       Impact factor: 9.461

5.  Correlation of serum adipocytokine levels with glycolipid metabolism and inflammatory factors in obese patients with periodontal disease.

Authors:  Zejian Li; Chunting Lu; Jiayu Qiu; Shengwen Liu; Xiaoqi Liu; Shuyuan Ma; Renfa Lai
Journal:  Int J Clin Exp Pathol       Date:  2018-03-01

6.  Gingival crevicular fluid and serum visfatin concentration: their relationship in periodontal health and disease.

Authors:  A R Pradeep; N M Raghavendra; M V Ramchandra Prasad; Rahul Kathariya; Swati Pradeep Patel; Anuj Sharma
Journal:  J Periodontol       Date:  2011-02-10       Impact factor: 6.993

7.  Visfatin levels in gingival crevicular fluid and serum before and after non-surgical treatment for periodontal diseases.

Authors:  Çiğdem Coşkun Türer; Umut Balli; Berrak Güven; Burcu Özkan Çetinkaya; Gonca Çayır Keleş
Journal:  J Oral Sci       Date:  2016       Impact factor: 1.556

8.  Increased visfatin expression is associated with nuclear factor-kappa B and phosphatidylinositol 3-kinase in periodontal inflammation.

Authors:  Erkan Özcan; N Işıl Saygun; Rahşan Ilıkçı; Yıldırım Karslıoğlu; Uğur Muşabak; Sait Yeşillik
Journal:  Clin Oral Investig       Date:  2016-06-09       Impact factor: 3.573

9.  Salivary visfatin concentrations in patients with chronic periodontitis.

Authors:  Zahra Alizadeh Tabari; Abbas Azadmehr; Ali Nohekhan; Nima Naddafpour; Fatemeh Baharak Ghaedi
Journal:  J Periodontol       Date:  2013-11-14       Impact factor: 6.993

10.  The role of visfatin levels in gingival crevicular fluid as a potential biomarker in the relationship between obesity and periodontal disease.

Authors:  Deniz Çetiner; Ahu Uraz; Seniha Öztoprak; Gülçin Akça
Journal:  J Appl Oral Sci       Date:  2019-07-29       Impact factor: 2.698

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.